We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

Enhancing Evidence Generation across the Product Life Cycle

Track:
Can Regulators and HTA Bodies Create Synergies for Patient Access?

Day & Time:
April 18, 4:00PM - 5:30PM (Central Europe Standard Time)

Session Number:
S0103

Room Number:
Sydney

Type:
Session

Title:
Enhancing Evidence Generation across the Product Life Cycle

Chair(s):
Alison Cave, PhD
Principal Scientific Administrator
European Medicines Agency (EMA), United Kingdom

Description:
Enhancing Evidence Generation across the Product Life Cycle

Presentation(s) & Speaker(s):
Use of Registry Data for Defining Clinical Care Pathways, Unmet Need and the Future – Registry Trails
Edward McKone
Professor, School of Medicine
St. Vincent's University Hospital, Ireland

Upholding and Enhancing Robust and Effective Real World Evidence Generation
Andrew Bate, PhD, MA
Senior Director, Analytics Team Lead, WSR Epidemiology
Pfizer Inc, United Kingdom

Panel Discussion
John Rigg
Head of Predictive Analytics
IQVIA, United Kingdom

Panel Discussion
David Martin, MD, MPH
Associate Director for Real World Evidence Analytics
FDA, United States

Panel Discussion
Deborah Morrison
Senior Scientific Adviser
National Institute for Health and Care Excellence (NICE), United Kingdom